Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01626053 · ClinicalTrials.gov registry record · NA

The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes

A NA study of Type 2 Diabetes Mellitus, sponsored by KRJG Services.

Completed
Registry status
NA
Development phase
182
Enrollment target
1
Study location

NCT01626053 is a NA study of Type 2 Diabetes Mellitus that has completed, run by KRJG Services. The registered enrollment target is 182 participants, below the 2,747-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01626053, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by KRJG Services.

COMPLETED
Registry status
NA
Development phase
182 participants
Enrollment target
1
Study location

Study Summary

It is hypothesized for this study that the coupling of the Millon Behavioral Medicine Diagnostic, biopsychosocial evaluation, motivational interviewing, relapse prevention, and ongoing support can produce improved outcomes with diabetics who have previously been unsuccessful with the traditional care. This study examined the relationship between patients' HbA1c levels and patients' involvement in the ASMART program, a multifaceted program involving psychological intervention. The study was conducted through the Kosciusko Health Department and funded by K21 Health Foundation.

Conditions Studied

Interventions

  • OTHER Control Group
  • BEHAVIORAL ASMART

Study Locations (1)

Indiana

  • Northern Lakes Medicine - Warsaw

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2009-03
Est. Completion 2011-06
Phase NA

Sponsor

KRJG Services

1 total trials

What the Registry Record Tells You About NCT01626053

The ClinicalTrials.gov registry entry for NCT01626053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,747-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (93% lower). The listed sponsor is KRJG Services, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.

NCT01626053 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT01626053 about?

NCT01626053 is a clinical study titled "The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes". It is hypothesized for this study that the coupling of the Millon Behavioral Medicine Diagnostic, biopsychosocial evaluation, motivational interviewing, relapse prevention, and ongoing support can produce improved outcomes with diabetics who have previously been unsuccessful with the traditional car...

What is the current status of trial NCT01626053?

This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2009-03. Estimated completion is 2011-06.

What conditions does trial NCT01626053 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT01626053?

The interventions under investigation include: Control Group (OTHER), ASMART (BEHAVIORAL).

Who is sponsoring clinical trial NCT01626053?

This trial is sponsored by KRJG Services, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01626053 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.